⌘K
t
| Date | 28 Apr 2022 |
| Time | 11:00:02 |
| Category | Director/PDMR dealings |
| ID | 7156J |
IQE plc
Cardiff, UK
28 April 2022
Director/PDMR Shareholding
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 27 April 2022 that on that date Dr Drew Nelson, President and Non-Executive of the Company, purchased 250,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares").
This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") |
|
|
a) |
Name |
Dr Drew Nelson |
|
2. |
Reason for the notification |
|
|
a) |
Position / status |
PDMR (President and Non-Executive Director) |
|
b) |
Initial notification / amendment |
Initial notification
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
IQE plc
|
|
b) |
Legal Entity Identifier |
213800Y33WHD3ESJJP16
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument |
Ordinary shares of 1 pence each in the Company
|
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares
|
|
c) |
Price(s) and volume(s) |
250,000 Ordinary Shares at an average price of 30.2p per Ordinary Share |
|
d) |
Aggregated information · Aggregated volume · Aggregated price |
Aggregated volume: 250,000 Aggregated price: £75,500 |
|
e) |
Date of the transaction(s) |
27 April 2022
|
|
f) |
Place of the transaction |
London Stock Exchange, AIM (AIMX)
|
Contacts:
IQE plc
+44 (0) 29 2083 9400
Americo Lemos
Tim Pullen
Amy Barlow
Peel Hunt LLP (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Edward Knight
Paul Gillam
James Smith
Citigroup Global Markets Limited (Joint Broker)
+44 (0) 20 7986 4000
Christopher Wren
Peter Catterall
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Antonia Pollock: +44 (0) 7789 954 356
ABOUT IQE
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:
· handset devices
· global telecoms infrastructure
· connected devices
· 3D sensing
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with c. 670 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.